As of Apr 24
| -0.54 / -1.06%|
The 5 analysts offering 12-month price forecasts for KYTHERA Biopharmaceuticals Inc have a median target of 61.00, with a high estimate of 85.00 and a low estimate of 50.00. The median estimate represents a +20.94% increase from the last price of 50.44.
The current consensus among 5 polled investment analysts is to Buy stock in KYTHERA Biopharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.